Abbott Profit Rises 12 Percent In Fourth-quarter


Salon Staff
January 25, 2012 6:27PM (UTC)

WASHINGTON (AP) — Medical device and drugmaker Abbott Laboratories says its profit increased more than 12 percent in the fourth-quarter on double-digit sales growth of its top-selling drug Humira.

Abbott reported net income of $1.62 billion, or $1.02 per share, for the last three months of 2011. That's up from $1.44 billion, or 92 cents per share, in the prior-year period.

Advertisement:

Excluding one-time items the company earned $1.45 per share. Analysts polled by FactSet expected $1.44 per share.

Revenue rose to $10.4 billion. Analysts expected revenue of $10.6 billion.

In October, Abbott said that it would spin off its branded drug business into a separate company. The split is expected before the end of the year.

As in prior quarters, top-selling anti-inflammatory drug Humira dominated the company's results, contributing over 20 percent of sales.


Salon Staff

MORE FROM Salon Staff

BROWSE SALON.COM
COMPLETELY AD FREE,
FOR THE NEXT HOUR

Read Now, Pay Later - no upfront
registration for 1-Hour Access

Click Here
7-Day Access and Monthly
Subscriptions also available
No tracking or personal data collection
beyond name and email address

•••


Fearless journalism
in your inbox every day

Sign up for our free newsletter

• • •